Tag: ACAD

After releasing positive clinical data, ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is making a run for the top in the market this morning. The data came...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is having a great start to the trading session this morning after reporting its financial results for the first...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is having an overwhelmingly strong start to the trading session this morning after announcing poster presentation sof clinical data...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is having a strong start to the trading session this morning after rumors broke surrounding the company. The rumors...

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) Acadia Pharmaceuticals wasn't off to the best of days in today's trading session. When the market opened, the stock was...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ACADIA Pharmaceuticals was off to a relatively normal day in the market today. At the open, the stock was trading...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ACADIA Pharmaceuticals was off to what seemed to be a relatively normal day in the market today. When the opening...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ACADIA Pharmaceuticals didn't have the best of days in the market yesterday. In fact, the stock ended the day at...

Acadia Pharmaceuticals (NASDAQ:ACAD) On Monday, Acadia Pharmaceuticals announced that it had initiated a phase 2 trial in patients with Alzheimer's Disease Agitation. Once again ACAD...